移民中疟原虫感染率:系统综述与Meta分析
该研究系统检索多个数据库,纳入23项在非流行地区对移民进行系统性筛查的研究(PCR数据4203人、显微镜数据3186人、快速诊断试验数据4698人)。撒哈拉以南非洲移民的疟原虫合并感染率经PCR为8.3%(95%CI 5.1-12.2),快速诊断试验为4.3%(1.5-8.2),显微镜为3.1%(0.7-6.8)。作者认为这些估计有助于为移民疟疾筛查策略和指南提供信息。
要点
- 撒哈拉以南非洲移民的疟原虫合并感染率经PCR为8.3%(95%CI 5.1-12.2),快速诊断试验为4.3%(1.5-8.2),显微镜为3.1%(0.7-6.8)。
- 亚洲移民经PCR的合并感染率为0%(95%CI 0.0-0.08),拉丁美洲移民为0.4%(95%CI 0.0-1.8)。
- 中非地区移民的PCR合并感染率最高为9.3%(95%CI 6.0-13.0),西非移民为2.0%(95%CI 0.0-7.7)。
核心结论
- 研究提供了非流行地区移民的疟原虫合并感染率估计,尽管不同环境间存在异质性,这些发现可有助于为移民疟疾筛查策略和指南提供信息。
研究设计与样本
- 系统综述与Meta分析,纳入23项在非流行地区通过系统性筛查招募移民并报告疟疾感染率数据的横断面研究以及观察性前瞻性或回顾性队列研究。
- 共纳入PCR数据4203名参与者、显微镜数据3186名、快速诊断试验数据4698名。
- 文献检索范围包括MEDLINE-Ovid、EMBASE、Web of Science、Global Health、Lilacs、Cochrane和MedRxiv。
- 纳入研究限定于在欧洲、美国、加拿大、澳大利亚或新西兰开展,不限语言或发表状态。
- 排除了因疟疾症状而接受检测者的研究,并采用标准化且经验证的评估工具(Joanna Briggs Institute Manual for Evidence Synthesis)评估偏倚风险。
主要发现
- 撒哈拉以南非洲移民的疟原虫合并感染率:PCR为8.3%(95%CI 5.1-12.2),快速诊断试验为4.3%(1.5-8.2),显微镜为3.1%(0.7-6.8)。
- 亚洲移民经PCR的合并感染率为0%(95%CI 0.0-0.08),拉丁美洲移民为0.4%(95%CI 0.0-1.8)。
- 中非地区移民的PCR合并感染率最高为9.3%(95%CI 6.0-13.0),西非移民为2.0%(95%CI 0.0-7.7)。
- 将分析限定于抵达宿主国前一年内到达的撒哈拉以南非洲移民,基于PCR的合并感染率为11.6%(95%CI 6.9-17.4)。
- 异质性通过按年龄、来源地区、研究时间和研究质量进行分层来探索。
临床怎么用
- 研究结论指出,尽管不同环境间存在异质性,这些发现可有助于为移民疟疾筛查策略和指南提供信息。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Asymptomatic malaria infections are highly prevalent in endemic areas. OBJECTIVES: This systematic review aimed to estimate the pooled prevalence of malaria parasites in migrants screened in non-endemic areas. DATA SOURCES: MEDLINE-Ovid, EMBASE, Web of Science, Global Health, Lilacs, Cochrane, and MedRxiv. STUDY ELIGIBILITY CRITERIA: Cross-sectional studies and observational prospective or retrospective cohort studies conducted in Europe, USA, Canada, Australia, or New Zealand regardless of language or publication status. Studies should include prevalence data on malaria in migrants that were recruited through a systematic screening approach. We excluded studies where people were tested because of malaria symptoms. PARTICIPANTS: Migrant individuals exposed to malaria infection ASSESSMENT OF RISK OF BIAS: A standardized and validated appraisal instrument was used for studies reporting prevalence data (Joanna Briggs Institute Manual for Evidence Synthesis). METHODS OF DATA SYNTHESIS: Pooled estimates of the parasite prevalence by PCR, microscopy, and rapid diagnostic test (RDT) were calculated with a random-effects model. Heterogeneity was explored by stratification by age, region of origin, period of study, and quality of studies. RESULTS: Of 1819 studies retrieved, 23 studies were included with in total 4203 participant PCR data, 3186 microscopy and 4698 RDT data, respectively. Migrants from sub-Saharan Africa had a malaria parasite prevalence of 8.3% (95% CI 5.1-12.2) by PCR, 4.3% (1.5-8.2) by RDT, and 3.1% (0.7-6.8) by microscopy. For migrants from Asia and Latin America, the prevalence with PCR was 0% (0.0-0.08) and 0.4% (0.0-1.8), respectively. Migrants from the Central African Region had the highest PCR prevalence (9.3% [6.0-13.0]), followed by West African migrants (2.0% [0.0-7.7]). Restricting the analysis to sub-Saharan Africa migrants arriving to the host country within the previous year, the PCR-based prevalence was 11.6% (6.9-17.4). CONCLUSION: We provide estimates on the malaria parasite prevalence in migrants in non-endemic setting. Despite heterogeneity between settings, these findings can contribute to inform screening strategies and guidelines targeting malaria in migrants.
引用
- Requena-Méndez A, Cattaneo P, Bogale RT, et al. Malaria parasite prevalence among migrants: a systematic review and meta-analysis. Clin Microbiol Infect. 2023. PMID: 37739263. doi:10.1016/j.cmi.2023.09.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。